| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman Washington 99164-4231
Address all correspondence and requests for reprints to: Michael K. Skinner, Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, Washington 99164-4231. E-mail: skinner{at}mail.wsu.edu.
Embryonic exposure to the endocrine disruptor vinclozolin at the time of gonadal sex determination was previously found to promote transgenerational disease states. The actions of vinclozolin appear to be due to epigenetic alterations in the male germline that are transmitted to subsequent generations. Analysis of the transgenerational epigenetic effects on the male germline (i.e. sperm) identified 25 candidate DNA sequences with altered methylation patterns in the vinclozolin generation sperm. These sequences were identified and mapped to specific genes and noncoding DNA regions. Bisulfite sequencing was used to confirm the altered methylation pattern of 15 of the candidate DNA sequences. Alterations in the epigenetic pattern (i.e. methylation) of these genes/DNA sequences were found in the F2 and F3 generation germline. Therefore, the reprogramming of the male germline involves the induction of new imprinted-like genes/DNA sequences that acquire an apparent permanent DNA methylation pattern that is passed at least through the paternal allele. The expression pattern of several of the genes during embryonic development were found to be altered in the vinclozolin F1 and F2 generation testis. A number of the imprinted-like genes/DNA sequences identified are associated with epigenetic linked diseases. In summary, an endocrine disruptor exposure during embryonic gonadal sex determination was found to promote an alteration in the epigenetic (i.e. induction of imprinted-like genes/DNA sequences) programming of the male germline, and this is associated with the development of transgenerational disease states.
This article has been cited by other articles:
![]() |
T. C. King Heiden, J. Spitsbergen, W. Heideman, and R. E. Peterson Persistent Adverse Effects on Health and Reproduction Caused by Exposure of Zebrafish to 2,3,7,8-Tetrachlorodibenzo-p-dioxin During Early Development and Gonad Differentiation Toxicol. Sci., May 1, 2009; 109(1): 75 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Foley, J. M. Craig, R. Morley, C. J. Olsson, T. Dwyer, K. Smith, and R. Saffery Prospects for Epigenetic Epidemiology Am. J. Epidemiol., February 15, 2009; 169(4): 389 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Recabarren, P. P. Rojas-Garcia, M. P. Recabarren, V. H. Alfaro, R. Smith, V. Padmanabhan, and T. Sir-Petermann Prenatal Testosterone Excess Reduces Sperm Count and Motility Endocrinology, December 1, 2008; 149(12): 6444 - 6448. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Fleming, T. H-M. Huang, and A. E. Toland The Role of Parental and Grandparental Epigenetic Alterations in Familial Cancer Risk Cancer Res., November 15, 2008; 68(22): 9116 - 9121. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Foster Environmental Estrogens and Endocrine Disruption: Importance of Comparative Endocrinology Endocrinology, September 1, 2008; 149(9): 4267 - 4268. [Full Text] [PDF] |
||||
![]() |
N. M Zamudio, S. Chong, and M. K O'Bryan Epigenetic regulation in male germ cells Reproduction, August 1, 2008; 136(2): 131 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E Nilsson, M. D Anway, J. Stanfield, and M. K Skinner Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease Reproduction, May 1, 2008; 135(5): 713 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wyman, A. B. Pinto, R. Sheridan, and K. H. Moley One-Cell Zygote Transfer from Diabetic to Nondiabetic Mouse Results in Congenital Malformations and Growth Retardation in Offspring Endocrinology, February 1, 2008; 149(2): 466 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yauk, A. Polyzos, A. Rowan-Carroll, C. M. Somers, R. W. Godschalk, F. J. Van Schooten, M. L. Berndt, I. P. Pogribny, I. Koturbash, A. Williams, et al. Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location PNAS, January 15, 2008; 105(2): 605 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Oakes, T. L. J. Kelly, B. Robaire, and J. M. Trasler Adverse Effects of 5-Aza-2'-Deoxycytidine on Spermatogenesis Include Reduced Sperm Function and Selective Inhibition of de Novo DNA Methylation J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1171 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Crews, A. C. Gore, T. S. Hsu, N. L. Dangleben, M. Spinetta, T. Schallert, M. D. Anway, and M. K. Skinner Transgenerational epigenetic imprints on mate preference PNAS, April 3, 2007; 104(14): 5942 - 5946. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Price, S. K. Murphy, and E. V. Younglai Perspectives: The Possible Influence of Assisted Reproductive Technologies on Transgenerational Reproductive Effects of Environmental Endocrine Disruptors Toxicol. Sci., April 1, 2007; 96(2): 218 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Merlet, C. Racine, E. Moreau, S. G. Moreno, and R. Habert Male fetal germ cells are targets for androgens that physiologically inhibit their proliferation PNAS, February 27, 2007; 104(9): 3615 - 3620. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Zoeller Endocrine Disruptors: Do Family Lines Carry an Epigenetic Record of Previous Generations' Exposures? Endocrinology, December 1, 2006; 147(12): 5513 - 5514. [Full Text] [PDF] |
||||
![]() |
M. D. Anway, C. Leathers, and M. K. Skinner Endocrine Disruptor Vinclozolin Induced Epigenetic Transgenerational Adult-Onset Disease Endocrinology, December 1, 2006; 147(12): 5515 - 5523. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |